Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, RNAi Antisense Therapeutics, Capsid Inhibitors, Others), By Application (HIV, Hepatitis, Herpes, Influenza, Respiratory Syncytial Virus, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 21, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
  7. North America Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  8. Europe Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  9. APAC Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  10. Middle East and Africa Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  11. LATAM Antiviral Drugs Market Size Analysis
    1. Introduction
    2. Antiviral Drugs Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. DNA Polymerase Inhibitors
      2. Reverse Transcriptase Inhibitors
      3. Protease Inhibitors
      4. Neuraminidase Inhibitors
      5. RNAi Antisense Therapeutics
      6. Capsid Inhibitors
      7. Others
    3. Antiviral Drugs Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. HIV
      2. Hepatitis
      3. Herpes
      4. Influenza
      5. Respiratory Syncytial Virus
      6. Others
    4. Antiviral Drugs Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. DNA Polymerase Inhibitors
        2. Reverse Transcriptase Inhibitors
        3. Protease Inhibitors
        4. Neuraminidase Inhibitors
        5. RNAi Antisense Therapeutics
        6. Capsid Inhibitors
        7. Others
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. HIV
        2. Hepatitis
        3. Herpes
        4. Influenza
        5. Respiratory Syncytial Virus
        6. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Online Pharmacy
  12. Competitive Landscape
    1. Antiviral Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Hoffmann-La Roche Ltd. (Switzerland)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gilead Sciences, Inc. (US)
    3. Merck Co., Inc. (US)
    4. Pfizer Inc. (US)
    5. AbbVie Inc. (US)
    6. Johnson & Johnson (US)
    7. Bristol Myers Squibb (US)
    8. Viatris Inc. (US)
    9. GSK plc (UK)
    10. Sanofi S.A. (France)
    11. Boehringer Ingelheim International GmbH (Germany)
    12. Teva Pharmaceutical Industries Ltd. (Israel)
    13. Reddy's Laboratories Ltd. (India)
    14. Cipla Limited (India)
    15. Sun Pharmaceutical Industries Ltd. (India)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Antiviral Drugs Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 3: Global Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 4: Global Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 5: North America Antiviral Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 7: North America Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 8: North America Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 9: U.S. Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 10: U.S. Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 11: U.S. Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 12: Canada Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 13: Canada Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 14: Canada Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 15: Europe Antiviral Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 17: Europe Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 18: Europe Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 19: U.K. Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 20: U.K. Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 21: U.K. Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 22: Germany Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 23: Germany Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 24: Germany Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 25: France Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 26: France Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 27: France Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Spain Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 29: Spain Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 30: Spain Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 31: Italy Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 32: Italy Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 33: Italy Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 34: Russia Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 35: Russia Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 36: Russia Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 37: Nordic Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 38: Nordic Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 39: Nordic Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 40: Benelux Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 41: Benelux Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 42: Benelux Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 43: Rest of Europe Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 44: Rest of Europe Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 45: Rest of Europe Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 46: APAC Antiviral Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 48: APAC Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 49: APAC Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 50: China Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 51: China Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 52: China Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 53: Korea Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 54: Korea Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 55: Korea Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Japan Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 57: Japan Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 58: Japan Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 59: India Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 60: India Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 61: India Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 62: Australia Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 63: Australia Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 64: Australia Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 65: Taiwan Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 66: Taiwan Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 67: Taiwan Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 68: South East Asia Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 69: South East Asia Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 70: South East Asia Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 74: Middle East and Africa Antiviral Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 76: Middle East and Africa Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 78: UAE Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 79: UAE Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 80: UAE Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: Turkey Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 82: Turkey Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 83: Turkey Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 84: Saudi Arabia Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 85: Saudi Arabia Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 86: Saudi Arabia Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 87: South Africa Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 88: South Africa Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 89: South Africa Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 90: Egypt Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 91: Egypt Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 92: Egypt Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 93: Nigeria Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 94: Nigeria Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 95: Nigeria Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 96: Rest of MEA Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 97: Rest of MEA Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 98: Rest of MEA Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 99: LATAM Antiviral Drugs Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 101: LATAM Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 102: LATAM Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 103: Brazil Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 104: Brazil Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 105: Brazil Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 106: Mexico Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 107: Mexico Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 108: Mexico Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 109: Argentina Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 110: Argentina Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 111: Argentina Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 112: Chile Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 113: Chile Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 114: Chile Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 115: Colombia Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 116: Colombia Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 117: Colombia Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 118: Rest of LATAM Antiviral Drugs Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 119: Rest of LATAM Antiviral Drugs Market Size and Forecast By Application - 2022-2034 (USD Billion)

Table 120: Rest of LATAM Antiviral Drugs Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

We are featured on: